Abstract
In recent years scientific progress has dramatically raised the potential of genetic services, but the actual benefits of these developments are not universally shared. In countries of low and middle incomes, improvements in genetic services frequently lag behind. Since this is generally caused by lack of resources and not by the lack of political will, the question arises, how can one most easily acquire the necessary capital to improve the health care in these areas. Public–private partnerships (PPPs) offer one approach to solve this issue, aiming at the inclusion of private enterprises in the realisation of public authority services. So far PPPs have been used exclusively in other health service areas. In this paper a first attempt is being made to discuss the feasibility of transferring the concept of PPP to genetic services, and consideration is given as to where the most promising starting point might be. We start by defining a multilevel structure that needs to be considered in providing comprehensive genetic care. We continue by explaining the concept of PPPs and their current types of implementation in medical services. We then examine how the PPP model could be applied to genetic services or sections thereof. We arrive at the conclusion that a likely starting point for PPP in genetic services is at the level of the infrastructure building service.
Similar content being viewed by others
References
Axelsson H, Bustreo F, Harding H (2003) Private sector participation in child health. The World Bank Group, Washington
Barr AD (2007) A research protocol to evaluate the effectiveness of public–private partnerships as a means to improve health and welfare systems worldwide. Am J Public Health 97:19–25
Bazzoli GJ, Stein R, Alexander JA, Conrad DA, Sofaer S, Shortell SM (1997) Public–private collaboration in health and human service delivery: evidence from community partnerships. Milbank Q 75:533–561
Bell J (1998) The new genetics in clinical practice. BMJ 316:618
Bennett C, Burke S, Burton H, Farndon P (2010) A toolkit for incorporating genetics into mainstream medical services: learning from service development pilots in England. BMC Health Serv Res 10:125
Björkmann JW (2008) Public-private partnerships in health care services of less developed countries. Manuscript available from the author
Blagescu M, Young J (2005) Partnerships and accountability: current thinking and approaches among agencies supporting Civil Society Organisations. Working Paper 255, London; Overseas Development Institute http://kms1.isn.ethz.ch/serviceengine/Files/ISN/22721/ipublicationdocument_singledocument/0D762521-9F6E-4EA2-868D-2465F6038655/en/wp255.pdf. Accessed 26 Dec 2010
Bovis C (2010) Editorial—Public private partnerships: the challenges and opportunities for delivering public services in the 21st century. EPPPL 01/2010:1–14
Brown D (2008) The portfolio approach to successful product development in global health. In: Matlin S, Francisco A, Sundaram L, Faich H-S, Gehner M (eds) Health partnerships review. Global Forum for Health Research, Geneva
Bühner R (2004) Betriebswirtschaftliche Organisationslehre. Oldenburg, München 196–197
Burke W, Khoury MJ, Stewart A, Zimmern RL (2006) The path from genome-based research to population health: development of an international public health genomics network. Genet Med 8:451–458
Buse K, Walt G (2000a) Global public–private partnerships: part I—a new development in health? Bull World Health Organ 78:549–561
Buse K, Walt G (2000b) Global public–private partnerships: part II—what are the health issues for global governance? Bull World Health Organ 78:699–709
Buse K, Waxman A (2001) Public-private health partnerships: a strategy for WHO bulletin of the WHO. Bull World Health Organ 79:748–754
Maternal and Child Health Bureau (2000) Title V Block Grant program; guidance and forms for the Title V application and annual report. HRSA, MCHB, Department of Health and Human Services, OMB NO 0915–0172
Christianson A, Zimmern R, Kristoffersson U, J. Schmidtke J, Kent A, Raouf R, Barreiro C, Nippert I (2011) Health needs assessment for medical genetic services for congenital disorders in middle- and low-income nations. J Comm Genet
Cohen D, Barton G, Gray J, Brain K (2004) Health economics and genetic service development: a familial cancer genetic example. Fam Cancer 3:61–67
Daiger SP (2005) Was the Human Genome Project worth the effort? Sci 308:362–364
Datta A (2009) Public–private partnerships in India: a case for reform? Econ Polit Wkly 44:73–78
Emery J, Hayflick S (2001) The challenge of integrating genetic medicine into primary care. BMJ 322:1027. doi:10.1136/bmj.322.7293.1027
Fozouni B, Güntert B (2000) Prioritätensetzung im deutschen Gesundheitswesen—die Triade zwischen Rationierung, Rationalisierung und rationaler Allokation. Gesundheitswesen 62:559–567
Goel NK, Galhotra A, Swami HM (2007) Public private partnerships in the health sector. The Internet Journal of Health. http://www.ispub.com/journal/the_internet_journal_of_health/volume_6_number_2_7/article/public_private_partnerships_in_the_health_sector.html. Accessed 26 Dec 2010
Gwatkin D, Guillot M (1999) The burden of disease among the global poor: current situation, future trends, and implications for strategy. World Bank, Washington
Gwen D (2008) PPP initiatives and the HR crisis in the health sector. Working paper. http://stpse.ro/atasamente/226_C_Working%20paper_V4.pdf. Accessed 26 Dec 2010
Jung H (2006) Allgemeine Betriebswirtschaftslehre. Oldenburg, München
Karki DK, Mirzoev TN, Green AT, Newell JN, Baral SC (2007) Costs of a successful public–private partnership for TB control in an urban setting in Nepal. BMC Public Health. doi:10.1186/1471-2458-7-84
Kaye CI, Laxova R, Livingston JE, Lloyd-Puryear MA, Mann M, McCabe E, Therrell BL (2001) Integrating genetic services into public health—guidance for state and territorial programs from the National Newborn Screening and Genetics Resource Center (NNSGRC). Community Genet 4:175–196
Kettler H, White K, Jordan S (2003) Valuing industry contributions to public–private partnerships for health product development. Initiative on Public-Private Partnerships for Health, Geneva
Kickbusch I, Quick J (1998) Partnerships for health in the 21st century. World Health Stat Q 51:68–74
Lüders J (2009) Public Private Partnership—Der Versuch einer kritischen Auseinandersetzung. GRIN, Norderstedt
Meredith S, Ziemba E (2008) The new landscape of product development partnerships (PDPs). In: Matlin S, Francisco A, Sundaram L, Faich H-S, Gehner M (eds) Health partnerships review. Global Forum for Health Research, Geneva
Mitchell-Weaver C, Manning B (1992) Public–private partnerships in third world development: a conceptual overview. Stud Comp Int Dev 26:45–67
Nikolic I, Maikisch H (2006) Public–private partnerships and collaboration in the health sector. An overview with case studies from recent European experience. Working paper. http://www-wds.worldbank.org/external/default/WDSContentServer/WDSP/IB/2006/11/01/000090341_20061101140721/Rendered/PDF/378070Public0p1artnerships01PUBLIC1.pdf. Accessed 17 Dec 2010
Nishtar S (2004) Public–private partnerships in health—a global call to action. Health Res Pol Syst. doi:10.1186/1478-4505-2-5
Nwaka S, Ridley RG (2003) Virtual drug discovery and development for neglected diseases through public–private partnerships. Nat Rev Drug Discov 2:919–928
Ollila E (2003) Health-related public–private partnerships and the United Nations. In: Deacon B, Ollila E, Koivusalo M, Stubbs P (eds) Global social governance: themes and prospects. Ministry for Foreign Affairs of Finland, Helsinki, pp 36–73
Osborne D, Gaebler T (1992) Reinventing government: how the entrepreneurial spirit is transforming the public sector. Addison-Wesley, New York
Paz-y-Miño C (2004) Genetic services in Ecuador. Community Genet 7:137–41
Pefile S (2003) Donation programmes for HIV/AIDS-related the early experience of the Diflucan® partnership programme and Viramune® donation programme. Initiative on Public-Private Partnerships for Health, Geneva
Peters DH, Phillips T (2004) Mectizan donation program: evaluation of a public–private partnership. Trop Med Int Health 9:A4–A1
Radwan I (2005) India - Private Health Services for the Poor. Discussion paper, 958 Washington, DC. http://siteresources.worldbank.org/HEALTHNUTRITIONANDPOPULATION/Resources/281627–1095698140167/RadwanIndiaPrivateHealthFinal.pdf. Accessed 14 Mai 2012
Raman AV, Björkman JW (2009) Public–private partnership in the provision of health care services to the poor in India. In: Dinello N, Shaoguang W (eds) China, India and beyond—development drivers and limitations. Edward Elger Publishing, Cheltonham, pp 143–172
Reich M (2000) Public–private partnerships for public health. Nat Med 6:617–620
Richter J (2004a) Public–private partnerships for health: a trend with no alternatives? Development 47:43–48
Richter J (2004b) Public-private partnerships and international health policy-making. Ministry of Foreign Affairs of Finland, Helsinki, http://formin.finland.fi/Public/Print.aspx?contentid=73317&nodeid=15458&culture=en-US&contentlan=2. Accessed 04 Jan 2011
Rosenau P (1999) The strengths and weaknesses of public–private policy partnerships. Am Behav Sci 43:10–34
Sinanovic E, Kumaranayake L (2006a) Financing and cost-effectiveness analysis of public–private partnerships: provision of tuberculosis treatment in South Africa. Cost Eff Resour Alloc. doi:10.1186/1478-7547-4-11
Sinanovic E, Kumaranayake L (2006b) Sharing the burden of TB/HIV? Costs and financing of public–private partnerships for tuberculosis treatment in South Africa. Trop Med Int Health 11:1466–1474
Smith R (2000) Vaccines and medicines for the world's poorest. Public–private partnerships seem to be essential. BMJ 320:952–953
The World Bank Partnerships Group (1998) Partnership for development: proposed actions for the World Bank. Discussion paper, Washington, DC. http://www.worldbank.org/html/extdr/pfd-discpaper.pdf. Accessed 24 Feb 2011
Transparency International (2010) The Corruption Perception Index 2010. ISBN 978-3-935711-60-9
United Nations (1997) Public–private partnerships: the enabling environment for development. http://unpan1.un.org/intradoc/groups/public/documents/un/unpan000727.pdf. Accessed 04 Jan 2011
Wheeler C, Berkley S (2001) Initial lessons from public–private partnerships in drug and vaccine development. WHO Bulletin 79:728–734
Widdus R (2001) Public–private partnerships for health: their main targets, their diversity, and their future directions. WHO Bulletin 79:713–720
Widdus R (2003) Public–private partnerships for health require thoughtful evaluation. Bull World Health Organ 81:235
Widdus R (2005) Public–private partnerships: an overview. Trans Roy Soc Trop Med Hyg 99:S1–8
Widdus R, White K (2004) Combating diseases associated with poverty–financing strategies for product development and the potential role of public–private partnerships. The Initiative on Public-Private Partnerships for Health (IPPPH), Geneva. http://www.who.int/intellectualproperty/topics/ppp/en/CombatingDiseases-Abridged.pdf. Accessed 04 Jan 2011
World Health Organisation (2007) Draft global strategy and plan of action on public health, innovation and intellectual property. http://apps.who.int/gb/phi/pdf/igwg2/PHI_IGWG2_ID3-en.pdf. Accessed 04 Jan 2011
Wright CF, Brice P, Stewart A, Burton H (2010) Realising the benefits of genetics for health. Lancet 376:1370–1371
Yaïch M (2009) Investing in vaccines for developing countries: how public–private partnerships can confront neglected diseases. Landes Biosci 5:368–369
Ziemba E (2004) Public–private partnerships for neglected diseases: opportunities to address pharmaceutical gaps for neglected diseases. Background paper. http://archives.who.int/prioritymeds/report/background/pubpriv.doc, Accessed 27 Apr 2012
Ziemba E (2005) Public–private partnerships for product development: financial, scientific and managerial issues as challenges to future success. Research report. http://www.who.int/intellectualproperty/studies/Ziemba.pdf, Accesses 26 Dec 2010
Acknowledgments
We would like to thank Dr. Hilary Harris for the support and critically reading the manuscript. Mike Gibson’s editorial help is gratefully acknowledged. All members of the Capability and GenTEE partnerships are thanked for discussions. This project was part of the CAPABILITY Special Support Action funded by the EC 6th Framework Programme, contract number: LSSG-CT-2006-037275.
Conflict of interest
The authors declare no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
This is a contribution to Special Issue: Capability.
Rights and permissions
About this article
Cite this article
Meier, F., Schöffski, O. & Schmidtke, J. Public–private partnership as a solution for integrating genetic services into health care of countries with low and middle incomes. J Community Genet 4, 309–320 (2013). https://doi.org/10.1007/s12687-012-0099-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12687-012-0099-8